AzTrials
AzTrials

FunctionalityNCT07637383

IMPACT OF A MULTICOMPONENT PHYSICAL EXERCISE PROGRAM ON THE FUNCTIONAL CAPACITY OF PATIENTS ADMITTED TO AN INTERMEDIATE CARE HOSPITAL. VIVIFRAIL FOR A BETTER VIG-FRAIL.

A study testing vivifrail in people with Functionality and Fragility, run by Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina at 1 site in Spain.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

INTRODUCTION Physical exercise in frail individuals has demonstrated benefits in variables such as reduced mortality risk and improved frailty and quality of life. Specifically, the most beneficial type appears to be multicomponent exercise, which includes strength, endurance, balance, and gait training. Read more about this study

Who is it for?
Ages 65 years and older
Conditions the study is for
Functionality, Fragility
What is being tested?
vivifrail
Could I receive a placebo?
No, everyone receives an active treatment
How many people
120 participants
Where
1 siteSpain
Study dates
18 Feb 2026to Feb 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 65 years and older
  • All sexes
  • No healthy volunteers
  • Older adult
  • baseline Barthel Index ≥60
  • ability to communicate, ambulate, and complete the exercise program

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Spain1 site, 1 recruiting
  • Hospital Sant Andreu. Sant Andreu Salut

    Manresa, Barcelona, 08240

    Raquel Gómez, doctor, 938743312 ext. 2201, rgomezcortijo@gmail.com

    Anna Ruiz, Phd, 938743312 ext. 2201, anna.ruiz@umedicina.cat

    Recruiting

Other trials in Spain

About this study

INTRODUCTION Physical exercise in frail individuals has demonstrated benefits in variables such as reduced mortality risk and improved frailty and quality of life. Specifically, the most beneficial type appears to be multicomponent exercise, which includes strength, endurance, balance, and gait training. Within this field, the VIVIFRAIL project is an internationally recognized physical exercise promotion program.

OBJECTIVES To analyze the effects of an individualized multicomponent physical exercise program as an effective method for preventing/improving functional status and frailty in individuals admitted to an intermediate care hospital (ICH).

Read more

To assess whether improvements in functionality/frailty are maintained 3-4 months after discharge and to evaluate the impact of the program on quality of life variables and health indicators at 6 months.

METHODOLOGY Design: randomized clinical trial with two groups (control and intervention) and 6 months of follow-up.

Study population: adults older than 65 years admitted to an intermediate care hospital (ICH).

Inclusion criteria: baseline Barthel Index ≥60, ability to communicate, ambulate, and complete the exercise program.

Primary variables: functionality (Short Physical Performance Battery - SPPB) and frailty (Frail-VIG Index).

Secondary variables: grip strength, depressive symptoms, fear of falling, mortality, institutionalization, hospital admissions/emergency room and primary care visits, level of physical activity, medications (number, analgesics, opioid use, antidepressants, anxiolytics), and quality of life.

Sample size: assuming a 15% loss to follow-up, the final required sample size is 120 patients. Linear mixed-effects models will be used with a significance level of 0.05.

Read the detailed description

Introduction:

-Background Frailty is defined as "a medical syndrome with multiple causes and contributing factors characterized by diminished strength, endurance, and physiological function, increasing an individual's vulnerability to developing increased dependency and/or death." Its prevalence is high and increases with age.

With aging, the functional capacity of the neuromuscular, cardiovascular, and respiratory systems progressively declines, increasing the risk of frailty.

The reduction in muscle strength/power together with functional loss is one of the main factors threatening patients' autonomy. This situation worsens after hospitalization due to bed rest, polypharmacy, and physical impairment following acute illnesses.

The benefits of physical exercise in aging, especially among frail individuals, have been the subject of numerous studies. Regular physical activity improves both physical and mental function globally and may reverse some effects of chronic diseases, helping older adults maintain mobility, independence, and autonomy (improved functional capacity). It has also been shown to reduce mortality risk and institutionalization while improving frailty and quality of life.

The effects of physical exercise may be comparable to or even greater than those of pharmacological treatments for the prevention of cardiovascular disease and mortality reduction, with minimal adverse effects. However, despite the proven benefits, participation rates in physical activity among older adults remain low.

In particular, multicomponent physical activity programs-which include strength, endurance, balance, and gait training-have shown the greatest benefit, proving to be effective tools for preventing sarcopenia and functional decline. They have also demonstrated utility in reducing falls, cognitive decline, and depressive symptoms. Furthermore, exercise has a modulatory role in inflammation, increasing nociceptive thresholds and modifying pain perception.

Within this type of physical training, the VIVIFRAIL project is an internationally recognized exercise promotion program for preventing frailty and falls in older adults, both in community and hospital settings. The effectiveness of this program has been demonstrated in multiple previous studies.

Despite the scientific evidence supporting exercise prescription as an excellent non-pharmacological intervention, it is still uncommon for exercise to form part of the therapeutic plan at hospital discharge. In addition, adherence to exercise programs is often difficult, mainly because of patient motivation deficits and insufficient follow-up by healthcare professionals.

This study aims to evaluate the impact of prescribing individualized multicomponent physical exercise at discharge from an intermediate care center and its medium-term impact on health outcomes such as functional capacity, quality of life, polypharmacy, pain control, falls, mood, muscle strength, institutionalization, hospitalization, and mortality.

Unlike previous studies, frailty in this study will be measured using the VIG-Frail Index, which provides a rapid, multidimensional, and effective assessment of frailty, with optimal predictive capacity for 2-year mortality.

Through multicomponent physical exercise, we aim to demonstrate improvements in frailty, functionality, quality of life, and emotional well-being in geriatric patients, thereby reducing the risk of institutionalization. We also believe it may improve caregivers' quality of life by reducing the level of support required as patient functionality improves.

The study proposes a change in the discharge model currently used in intermediate care hospitals, where the intervention plan will include the prescription of an individualized physical exercise program that has not previously been implemented.

-Working Hypothesis Patients admitted to an Intermediate Care Hospital (ICH) who participate in an individualized multicomponent physical exercise program during the 3-4 months following discharge will achieve greater improvements in functional status and frailty compared with those who do not participate in the program.

In the medium term (6 months), these individuals will also demonstrate improved quality of life and lower rates of institutionalization, hospital admissions, emergency department visits, primary care consultations, and mortality.

  • Objectives Primary Objective To evaluate functionality and frailty 3-4 months after discharge from intermediate care in a group of patients prescribed a home-based physical exercise program (VIVIFRAIL), and to compare them with a group of similar characteristics who did not receive this prescription.

Secondary Objectives

  • To evaluate and compare both groups at 3-4 months in terms of:
  • number of falls,
  • fear of falling,
  • polypharmacy,
  • number of analgesics,
  • use of opioids, antidepressants, and anxiolytics,
  • pain control,
  • muscle strength,
  • quality of life,
  • and mood status.
  • To evaluate 6-month mortality in the group receiving physical exercise prescription compared with the control group.
  • To evaluate healthcare resource utilization at 6 months, including emergency department visits, primary care consultations, hospitalizations, and institutionalization.
  • Methodology

Study Design Randomized clinical trial with two groups: control and intervention.

Study Setting This is a single-center study that will be conducted at Hospital de Sant Andreu, Sant Andreu Salut, Manresa, an Intermediate Care Hospital (ICH).

Reference Population Patients admitted to Hospital de Sant Andreu, Sant Andreu Salut, Manresa.

Study Subjects The study will be conducted in an Intermediate Care Hospital in Manresa (Sant Andreu Salut. Hospital de Sant Andreu). The hospital has 155 beds. Admissions mainly come from the referral acute care hospital (Hospital Sant Joan de Déu de Manresa, Fundació Althaia), either from the emergency department or inpatient wards. Admissions may also come directly from primary care settings, including private homes and nursing homes.

The study will include selected patients who meet the inclusion criteria and agree to participate.

Inclusion Criteria

  • Patients aged ≥65 years admitted to Hospital Sant Andreu (Manresa).
  • Baseline Barthel Index ≥60.
  • Ability to communicate, ambulate, and complete the exercise program.

Exclusion Criteria

  • Severe cognitive impairment.
  • Medical conditions contraindicating physical exercise, including:
  • severe valvular heart disease,
  • uncontrolled heart failure,
  • unstable angina,
  • recent myocardial infarction,
  • uncontrolled arrhythmias,
  • acute infectious disease,
  • uncontrolled hypertension,
  • myocarditis,
  • pericarditis,
  • active endocarditis,
  • aortic dissection,
  • poorly controlled diabetes mellitus,
  • recent fracture within the last month (strength training contraindication).

Withdrawal Criteria Participants will be withdrawn from the study if they develop any condition (decompensation, cardiovascular event, fracture, or others) that contraindicates or prevents continuation of the prescribed physical exercise intervention.

Withdrawn participants will not be replaced. No follow-up will be performed once the participant has discontinued the intervention.

Participant dropout will be considered in cases of:

  • inability to contact the participant for the scheduled follow-up video calls during months 1-2 (intervention group),
  • failure to attend the in-person visit at months 3-4,
  • voluntary decision to discontinue participation.

Adverse Event Monitoring The VIVIFRAIL program is a physical exercise intervention whose safety has already been demonstrated in previous studies. The exercises are simple and easy to understand, and participants will receive training before discharge regarding their correct performance.

Participants will receive brochures ("VIVIFRAIL passports"; see Annex 3) where they will record potential side effects such as pain, fatigue, or dyspnea during exercise sessions. In case of symptom onset during exercise, patients/caregivers will be advised to contact the research team using the telephone number/email provided before discharge.

Participants will also be informed of potential adverse effects when receiving the informed consent form.

Being tested
vivifrail
Keywords
Frailty, physical exercise, Quality of life
Medical subject headings
Frailty, Motor Activity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • vivifrailOther

    The VIVIFRAIL program consists of exercises combining:

    • strength,
    • endurance,
    • balance,
    • and gait training, adapted to the participant's functional level according to:
    • SPPB score,
    • gait speed. Based on these results, an individualized multicomponent exercise program (Programs A, B, C, or D) will be prescribed.

    The intervention will begin during hospitalization once the patient is clinically stable.

Study groups in NCT07637383
Study groupRoleWhat they receive
Control groupNo interventionParticipants assigned to the control group will follow the usual therapeutic plan and recommendations without individualized physical exercise prescription.
intervention groupOtherParticipants assigned to the intervention group will receive instruction from the principal investigator and trained physiotherapy staff regarding the VIVIFRAIL multicomponent physical exercise program.
Receives: Other: vivifrail

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. functionality

    functionality (Short Physical Performance Battery - SPPB)

    Measured: 12 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Jun 2026
  2. Study start18 Feb 2026
  3. Primary completionAug 2026 (estimated)
  4. Study completionFeb 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Model description
Design: randomized clinical trial with two groups (control and intervention) and 6 months of follow-up.
Masking
Single blind
Who is masked
Investigator
Enrolment
120 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07637383
Sponsor's protocol ID
11/7/2006A
Status last verified
May 2026
First submitted
28 May 2026
Last updated
9 Jun 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Data obtained through this study may be provided to qualified researchers with academic interest.

Questions about this trial

What is this clinical trial studying?

A study testing vivifrail in people with Functionality and Fragility, run by Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina at 1 site in Spain.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 9 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Raquel Gómez Cortijo (938743312 ext. 2201, rgomezcortijo@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

functionality (time frame: 12 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Jun 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in